Launch of new high-throughput screening tool for bio-macromolecular research, including vaccines for COVID-19 using the novel VHH camelid antibodies

January 11, 2021

JASCO Corporation (Tokyo, Japan) is pleased to announce the launch of the J-1500 HTCDplus, a newly developed high-throughput screening workstation for probing bio-macromolecular structure and function. Incorporating linear and circular dichroism and fluorescence spectroscopies with a new ‘application oriented’ user interface, the J-1500 HTCDplus is ideally suited to the study of proteins and nucleic acids and has already proven itself as a productive tool for research into vaccines for Covid 19 using the novel VHH camelid antibodies. New features include accurate liquid handling and transport for small volume samples, temperature controlled autosampler for microplates or vials. Measurement is made quickly using the latest high performance J-1500 circular dichroism spectrometer. In line with the latest requirements of the FDA, the system is configured with JASCO’s Spectra Manager cross-platform software with a 21 CFR part 11 compliant option developed under Alcoa + for dependable data integrity.

About the Author

Mr. Akao, is the Applications Group Manager at JASCO Corporation, with many years at the company working on applications in electronic and vibrational spectroscopy, and is an expert in IR and Raman spectroscopy.